Detalles de la búsqueda
1.
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos).
EClinicalMedicine
; 67: 102372, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38169790
2.
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial.
EBioMedicine
; 91: 104586, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099843
Resultados
1 -
2
de 2
1
Próxima >
>>